Louise von Stechow

AI is everywhere—it brings hopes of accelerating industrial processes and making our lives easier and our work more efficient. It also brings fears of inexplicable black-box calculations, unintended consequences, and the loss of human jobs.

In the pharmaceutical industry, AI opens up the possibility of developing medications more quickly and tailoring them more precisely to the needs of individual patients. But to truly revolutionize the multibillion-dollar process of drug development using AI, this requires the right strategies, technological foundations, and, above all, high-quality data.

In this keynote, Louise von Stechow explores the potential of AI beyond the hype and draft scenarios of what AI-driven drug development could look like.